Genmab — Januar 2020
-
Uafhængige forskere tester Genmabs daratumumab mod Alzheimers
Biotekselskabet Genmabs helt store sællert testes nu som en mulig behandling af Alzheimers.
(medwatch.dk)
-
Er det dette her: https://clinicaltrials.gov/ct2/show/NCT04070378
-
this is the NVS presentation pdf
if interested https://www.novartis.com/sites/www.novartis.com/files/q4-2019-investor-presentation.pdf -
Regulatory file submitted in US and EU
Easy-to-use autoinjector available upon launch,
enabling simple at-home self-administration and
improved patient experience
Strong scientific presence at major congresses
and in markets through 2020
Engaging with payers on rapid, broad early
access -
Angående 9:10 henviser de selv til Chen og til artiklen: "PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance", hvor de konkluderer, at "targeting PD-1+CD38hi CD8+ T cells may prevent the induction of resistance to anti-PD-1 therapy" Nature Immunology volume 20, pages1231–1243(2019)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
